Literature DB >> 10842581

Free radicals and hearing. Cause, consequence, and criteria.

P Evans1, B Halliwell.   

Abstract

Reactive oxygen and nitrogen species, including free radicals, are produced in the human body in both health and disease. In health, they may arise as regulatory mechanisms, intercellular signaling species, or as bacteriocidal agents. Their production is normally controlled by the antioxidant defense mechanisms that include intracellular enzymes--for example, glutathione peroxidase and superoxide dismutase--and low molecular-mass compounds such as vitamin E or ascorbic acid. Although repair mechanisms exist, some steady-state basal oxidative damage occurs in all individuals. Oxidative stress arises when there is a marked imbalance between the production and removal of reactive oxygen and nitrogen species. This may originate from an overproduction of these substances or from a depletion in the antioxidant defenses. Certain drugs may induce oxidative stress by forming drug-derived radicals that can not only deplete the antioxidant defenses but can also react directly with biomolecules. To be able to assess whether oxidative stress is occurring in a particular tissue, reliable biomarkers of oxidative damage are required. Since oxidative stress can damage all major biomolecules in vitro and probably in vivo, biomarkers for DNA, protein, and lipid damage are being developed which, when taken with an assessment of the antioxidant status of the individual, will allow evaluation of the involvement of oxidative stress in the etiology of disease and in the side effects of drugs. There is some evidence to suggest that free radical-mediated damage may be involved in the ototoxicity of aminoglycosides and cisplatin derivatives. Whether this is a cause or consequence of the toxic insult to the sensory hair cells of the inner ear remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10842581     DOI: 10.1111/j.1749-6632.1999.tb08633.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  56 in total

1.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  Current aspects of hearing loss from occupational and leisure noise.

Authors:  S Plontke; H-P Zenner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

3.  The design and screening of drugs to prevent acquired sensorineural hearing loss.

Authors:  Debashree Mukherjea; Leonard P Rybak; Kelly E Sheehan; Tejbeer Kaur; Vickram Ramkumar; Sarvesh Jajoo; Sandeep Sheth
Journal:  Expert Opin Drug Discov       Date:  2011-03-15       Impact factor: 6.098

Review 4.  Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.

Authors:  Colleen G Le Prell; Daisuke Yamashita; Shujiro B Minami; Tatsuya Yamasoba; Josef M Miller
Journal:  Hear Res       Date:  2006-12-04       Impact factor: 3.208

5.  Cisplatin ototoxicity and otoprotection with sodium salicylate.

Authors:  Miguel Angelo Hyppolito; José Antonio A de Oliveira; Maria Rossato
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-07       Impact factor: 2.503

6.  Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.

Authors:  Z Altun; Y Olgun; P Ercetin; S Aktas; G Kirkim; B Serbetcioglu; N Olgun; E A Guneri
Journal:  Cell Prolif       Date:  2013-11-29       Impact factor: 6.831

7.  Role of mannitol in reducing postischemic changes in distortion-product otoacoustic emissions (DPOAEs): a rabbit model.

Authors:  Krzysztof Morawski; Fred F Telischi; Faisal Merchant; Lidet W Abiy; Grazyna Lisowska; Grzegorz Namyslowski
Journal:  Laryngoscope       Date:  2003-09       Impact factor: 3.325

Review 8.  Radiation-induced fibrosis: mechanisms and implications for therapy.

Authors:  Jeffrey M Straub; Jacob New; Chase D Hamilton; Chris Lominska; Yelizaveta Shnayder; Sufi M Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-25       Impact factor: 4.553

9.  [Protection of the cochlea by ascorbic acid in noise trauma].

Authors:  I Fischer; U-R Heinrich; J Brieger; I Schmidtmann; H Li; A Rümelin; W J Mann; K Helling
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

10.  Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan.

Authors:  Mi-Jung Kim; Chul Han; Karessa White; Hyo-Jin Park; Dalian Ding; Kevin Boyd; Christina Rothenberger; Upal Bose; Peter Carmichael; Paul J Linser; Masaru Tanokura; Richard Salvi; Shinichi Someya
Journal:  Exp Gerontol       Date:  2020-08-28       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.